ARTICLE | Clinical News
Attenuon preclinical data
April 5, 2004 7:00 AM UTC
In a mouse model of breast cancer, tumors in animals treated with ATN-161 regressed or grew significantly more slowly than tumors in control animals. ATN-161 significantly decreased the number of tumo...